Spero Therapeutics (SPRO) Tax Provisions (2023 - 2025)
Spero Therapeutics' (SPRO) quarterly Tax Provisions came in at $261000.0 in Q4 2025, up 190.0% YoY from $90000.0 in Q4 2024, and up 190.0% on a QoQ basis from -$290000.0 in Q4 2024.
Spero Therapeutics (SPRO) Tax Provisions (2023 - 2025) Analysis & Trends
Spero Therapeutics (SPRO) has 3 years of Tax Provisions data on file, last reported at $261000.0 in Q4 2025.
- Quarterly Tax Provisions rose 190.0% year-over-year to $261000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $261000.0 (down 89.95% YoY) and the FY2025 annual result came in at $261000.0, changed N/A from the prior year.
- Tax Provisions advanced to $261000.0 in Q4 2025, from -$290000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.2 million in Q3 2023 to a low of -$290000.0 in Q4 2024.
- A 3-year average of $571800.0 and a median of $290000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions slumped 174.94% — and 2025, when it surged 190.0%.
- Tracing SPRO's Tax Provisions over 3 years: stood at $387000.0 in 2023, then slumped by 174.94% to -$290000.0 in 2024, then surged by 190.0% to $261000.0 in 2025.
- The last three Tax Provisions figures came in at $261000.0 (Q4 2025), -$290000.0 (Q4 2024), and $290000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | Spero Therapeutics | 71.88 Mn | 21.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 261,000.00 |
| Dec 31, 2024 | -290,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 2.21 Mn |